An Adaptive Optimal Design for theEmaxModel and Its Application in Clinical Trials
Authors:
- 11 February 2009
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 19 (2) , 360-385
Abstract
A project team working on a compound to treat Alzheimer's disease is carrying out a first-time-in-human dose-escalation study in patients. The team wished to maximize the efficiency of the study by using doses targeted at maximizing information about the dose-response relationship within certain safety constraints. We have developed an adaptive optimal design tool to recommend doses when the response follows an E max model, with functionality for pretrial simulation and in-stream analysis. We present the results of a simulation to investigate the operating characteristics of the applied algorithm.Keywords
This publication has 25 references indexed in Scilit:
- Optimal Designs for Estimating the Interesting Part of a Dose-Effect CurveJournal of Biopharmaceutical Statistics, 2007
- Adaptive Designs for Dose-Finding Studies Based on SigmoidEmaxModelJournal of Biopharmaceutical Statistics, 2007
- Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working GroupJournal of Biopharmaceutical Statistics, 2006
- Adaptive designs for dose-finding based on efficacy–toxicity responseJournal of Statistical Planning and Inference, 2006
- An evaluation of Bayesian designs for dose-escalation studies in healthy volunteersStatistics in Medicine, 2005
- Competing designs for phase I clinical trials: a reviewStatistics in Medicine, 2002
- Design of experiments with unknown parameters in varianceApplied Stochastic Models in Business and Industry, 2002
- Matrix Differential Calculus with Applications in Statistics and Econometrics.1988
- D-Optimal Designs for Partially Nonlinear Regression ModelsTechnometrics, 1980
- The Equivalence of Two Extremum ProblemsCanadian Journal of Mathematics, 1960